Feedback / Questions
cendakimab (RPC4046) - AbbVie, BMS
antolimab (AK002) - Allakos
Dupixent (dupilumab) - Sanofi, Regeneron
Entyvio (vedolizumab) - Takeda
http://www.ncbi.nlm.nih.gov/pubmed/32472465
Jun 1, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next